Celgene Corp., of Summit, N.J., appointed Rodman Drake to its board.

Ciphergen Biosystems Inc., of Fremont, Calif., appointed Kenneth Conway to its board.

CMEA Ventures, of San Francisco, appointed Rodney Altman senior partner to focus on medical devices, biotechnology therapeutics and diagnostics.

Coley Pharmaceutical Group Inc., of Wellesley, Mass., appointed Ferdinand Massari senior vice president, drug development and chief medical officer.

CombinatoRx Inc., of Cambridge, Mass., appointed Lynn Baird senior vice president, regulatory affairs, quality assurance and quality control.

Corautus Genetics Inc., of Atlanta, promoted Todd Stallings to vice president, clinical operations.

CoTherix Inc., of South San Francisco, appointed Abhay Joshi executive vice president and chief technical officer.

Cytos Biotechnology AG, of Zurich, Switzerland, appointed Othmar Vock to its board.